Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis-Reference-Cited by-同舟云学术

Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis

Published:2022-08 Issue: Volume:190 Page:109973
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Abiru Norio,Shoji Shingo,Kosakai Yoshinori,Snijder Robert,Asakawa Keiko,Rokuda Mitsuhiro

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. Type 1 diabetes;DiMeglio;Lancet,2018

2. Type 1 diabetes, metabolic syndrome and cardiovascular risk;Chillarón;Metabolism,2014

3. A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes-JDCP study 2;Nishimura;Diabetol Int,2016

4. SGLT2 inhibitors and renal complications in type 1 diabetes;Petrie;Lancet Diabetes Endocrinol,2020

5. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study;Dandona;Diabetes Care,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2i in Patients with Type 1 Diabetes: Benefits, Risks, and Preventive Strategies;Frontiers in Bioscience-Landmark;2023-05-22

2. Overlapping risk factors for diabetic ketoacidosis in patients with type 1 diabetes on ipragliflozin: case analysis of spontaneous reports in Japan from a pharmacovigilance safety database;Expert Opinion on Drug Safety;2023-04-11